Low serum high density lipoprotein cholesterol concentration is an independent predictor for enhanced inflammation and endothelial activation
- PMID: 25614985
- PMCID: PMC4304817
- DOI: 10.1371/journal.pone.0116867
Low serum high density lipoprotein cholesterol concentration is an independent predictor for enhanced inflammation and endothelial activation
Erratum in
-
Correction: Low Serum High Density Lipoprotein Cholesterol Concentration is an Independent Predictor for Enhanced Inflammation and Endothelial Activation.PLoS One. 2015 Nov 3;10(11):e0142245. doi: 10.1371/journal.pone.0142245. eCollection 2015. PLoS One. 2015. PMID: 26529413 Free PMC article. No abstract available.
Abstract
Background: Inflammation, endothelial activation and oxidative stress have been established as key events in the initiation and progression of atherosclerosis. High-density lipoprotein cholesterol (HDL-c) is protective against atherosclerosis and coronary heart disease, but its association with inflammation, endothelial activation and oxidative stress is not well established.
Objectives: (1) To compare the concentrations of biomarkers of inflammation, endothelial activation and oxidative stress in subjects with low HDL-c compared to normal HDL-c; (2) To examine the association and correlation between HDL-c and these biomarkers and (3) To determine whether HDL-c is an independent predictor of these biomarkers.
Methods: 422 subjects (mean age±SD = 43.2±11.9 years) of whom 207 had low HDL-c concentrations (HDL-c <1.0 mmol/L and <1.3 mmol/L for males and females respectively) and 215 normal controls (HDL-c ≥1.0 and ≥1.3 mmol/L for males and females respectively) were recruited in this study. The groups were matched for age, gender, ethnicity, smoking status, diabetes mellitus and hypertension. Fasting blood samples were collected for analysis of biomarkers of inflammation [high-sensitivity C-reactive protein (hsCRP) and Interleukin-6 (IL-6)], endothelial activation [soluble Vascular Cell Adhesion Molecule-1 (sVCAM-1), soluble Intercellular Adhesion Molecule-1 (sICAM-1) and E-selectin)] and oxidative stress [F2-Isoprostanes, oxidized Low Density Lipoprotein (ox-LDL) and Malondialdehyde (MDA)].
Results: Subjects with low HDL-c had greater concentrations of inflammation, endothelial activation and oxidative stress biomarkers compared to controls. There were negative correlations between HDL-c concentration and biomarkers of inflammation (IL-6, p = 0.02), endothelial activation (sVCAM-1 and E-selectin, p = 0.029 and 0.002, respectively), and oxidative stress (MDA and F2-isoprostane, p = 0.036 and <0.0001, respectively). Multiple linear regression analysis showed HDL-c as an independent predictor of IL-6 (p = 0.02) and sVCAM-1 (p<0.03) after correcting for various confounding factors.
Conclusion: Low serum HDL-c concentration is strongly correlated with enhanced status of inflammation, endothelial activation and oxidative stress. It is also an independent predictor for enhanced inflammation and endothelial activation, which are pivotal in the pathogenesis of atherosclerosis and atherosclerosis-related complications.
Conflict of interest statement
Similar articles
-
Enhanced status of inflammation and endothelial activation in subjects with familial hypercholesterolaemia and their related unaffected family members: a case control study.Lipids Health Dis. 2017 Apr 24;16(1):81. doi: 10.1186/s12944-017-0470-1. Lipids Health Dis. 2017. PMID: 28438163 Free PMC article.
-
Oral fat load effects on inflammation and endothelial stress markers in healthy subjects.Heart Vessels. 2009 May;24(3):204-10. doi: 10.1007/s00380-008-1109-y. Epub 2009 May 24. Heart Vessels. 2009. PMID: 19466522
-
Metabolic syndrome aggravates the increased endothelial activation and low-grade inflammation in subjects with familial low HDL.Ann Med. 2006;38(3):229-38. doi: 10.1080/07853890500526352. Ann Med. 2006. PMID: 16720437
-
High-sensitivity C-reactive protein and atherosclerotic disease: from improved risk prediction to risk-guided therapy.Int J Cardiol. 2013 Oct 15;168(6):5126-34. doi: 10.1016/j.ijcard.2013.07.113. Epub 2013 Aug 24. Int J Cardiol. 2013. PMID: 23978367 Review.
-
Probiotics improve renal function, glucose, lipids, inflammation and oxidative stress in diabetic kidney disease: a systematic review and meta-analysis.Ren Fail. 2022 Dec;44(1):862-880. doi: 10.1080/0886022X.2022.2079522. Ren Fail. 2022. PMID: 35611435 Free PMC article.
Cited by
-
Association of the HDL-c Level with HsCRP, IL-6, U-NAG, RBP and Cys-C in Type 2 Diabetes Mellitus, Hypertension, and Chronic Kidney Disease: An Epidemiological Survey.Diabetes Metab Syndr Obes. 2020 Oct 13;13:3645-3654. doi: 10.2147/DMSO.S265735. eCollection 2020. Diabetes Metab Syndr Obes. 2020. PMID: 33116716 Free PMC article.
-
The LDL/HDL ratio and atherosclerosis in ankylosing spondylitis.Z Rheumatol. 2017 Feb;76(1):58-63. doi: 10.1007/s00393-016-0092-4. Z Rheumatol. 2017. PMID: 27312464 English.
-
High-density lipoprotein cholesterol concentration and acute kidney injury after noncardiac surgery.BMC Nephrol. 2020 Apr 25;21(1):149. doi: 10.1186/s12882-020-01808-7. BMC Nephrol. 2020. PMID: 32334566 Free PMC article.
-
Association between WHO First-Step Analgesic Use and Risk of Breast Cancer in Women of Working Age.Pharmaceuticals (Basel). 2023 Feb 20;16(2):323. doi: 10.3390/ph16020323. Pharmaceuticals (Basel). 2023. PMID: 37259467 Free PMC article.
-
High-Density Lipoprotein Cholesterol Concentration and Acute Kidney Injury After Cardiac Surgery.J Am Heart Assoc. 2017 Dec 9;6(12):e006975. doi: 10.1161/JAHA.117.006975. J Am Heart Assoc. 2017. PMID: 29223955 Free PMC article. Clinical Trial.
References
-
- Wilson PWF, D'Agostino RB, Levy D, Belanger AM, Silbershatz H, et al. (1998) Prediction of Coronary Heart Disease Using Risk Factor Categories. Circulation 97: 1837–1847. - PubMed
-
- Whitlock LSG, Clarke R, Sherliker P, Emberson J, Halsey J, et al. (2007) Blood cholesterol and vascular mortality by age, sex, and blood pressure: a meta-analysis of individual data from 61 prospective studies with 55,000 vascular deaths. Lancet 370: 1829–1839. - PubMed
-
- Gordon T, Castelli WP, Hjortland MC, Kannel WB, Dawber TR (1977) High density lipoprotein as a protective factor against coronary heart disease: The Framingham study. The American Journal of Medicine 62: 707–714. - PubMed
-
- Nofer JR, Kehrel B, Fobker M, Lezkau B, Assmann G, et al. (2002) HDL and atherosclerosis beyond reverse cholesterol transport. Atherosclerosis 161: 1–16. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous